Leerink Partners logo

Leerink Partners

Crunchbase

Deals on record

1

Common Fundraising Type

Series C

Odyssey Therapeutics is a biotech firm specializing in developing precision immunomodulators and oncology medicines, with plans to advance multiple therapeutic programs into clinical studies.

Series C
$101M
12/05/2023
Article